Grant ID RP130516
Awarded On December 05, 2012
Title Clinical Application of Umbilical Cord Blood-Derived Designer T Cells
Program Academic Research
Award Mechanism Individual Investigator
Institution/Organization The University of Texas M.D. Anderson Cancer Center
Principal Investigator/Program Director Laurence Cooper
Cancer Sites Leukemia, Lymphoma
Contracted Amount $1,262,675
Lay Summary

Many leukemias and lymphomas arise from the cancerous transformation of B cells and patients with advanced disease may be successfully treated by umbilical cord blood transplantation (UCBT). This is a lifesaving procedure that infuses umbilical cord blood (UCB) after high dose chemotherapy and sometimes radiotherapy to restore the ability of the recipient to generate white blood cells (immune cells), red blood cells, and platelets. The engrafted immune system can recognize leukemia and lymphoma cells resulting in the cure of some patients. However, patients with aggressive leukemias and lymphomas still have a poor survival due to relapse of their tumor and we seek to improve their outcome by...

Read More